COMMUNIQUÉS West-GlobeNewswire

Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer
18/08/2026
FDA written feedback provides alignment on a potential pivotal Part B expansion of the ongoing REO 033 study Proposed pathway offers potential accelerated approval based on objective response rate and progression-free [...]
R1 to Acquire Humata Health, Enhancing Phare OS with AI-Powered Prior Authorization Automation and Payer-Provider Collaboration
18/08/2026
Acquisition Removes Friction from Complex Prior Authorizations to Benefit Patients, Clinicians, Providers, and Payers CHICAGO, Aug. 18, 2026 (GLOBE NEWSWIRE) -- R1 (“R1” or the “Company”), an industry leader in [...]
New LogicMark Survey Reveals Safety Concerns of Gen Z Women & Workarounds They've Adapted
18/08/2026
National Survey of 1,500 Gen Z Women Finds Near-Universal Vigilance, Widespread Drink-Tampering Fear, Outfit Tax on Everyday Safety, and Reporting Gap That Keeps Silence as the Norm LOUISVILLE, Ky., Aug. 18, 2026 (GLOBE [...]
Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors
18/08/2026
Dr. Ernest Brings Significant Value-based Care and Clinical Expertise ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its [...]
BioPorto activates the first US clinical site as part of the ProNephro AKI® U.S. Adult Urine NGAL Validation Study.
18/08/2026
August 18, 2026 Press Release BioPorto activates the first US clinical site as part of the ProNephro AKI ® U.S. Adult Urine NGAL Validation Study. COPENHAGEN, DENMARK, August 18, 2026 – BioPorto A/S (“BioPorto” or “ [...]
Akari Therapeutics Builds Momentum for AKTX-101 with Compelling Urothelial Cancer Data Supporting Differentiated ADC Strategy
18/08/2026
AKTX-101 demonstrated robust anti-tumor activity across multiple clinically relevant urothelial cancer preclinical models Data supports the potential of Akari’s novel PH1 RNA spliceosome-modulating payload to overcome [...]
Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch
18/08/2026
Deal valued at $11 million in cash, with $8 million at closing and up to $3 million in additional milestone payments over the next 18 months Divestiture further concentrates Elutia’s attention and resources on the [...]
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
18/08/2026
BRANFORD, Conn., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule [...]
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
18/08/2026
Dr. Camisasca joins Entera with 30 years of global pharmaceutical research and clinical development experience including roles at Sumitomo Pharma, Takeda, and Novartis Appointment further strengthens Entera’s clinical [...]
PROMIXX Pursuit Insulated Shaker Bottle Keeps Protein Shakes Ice Cold for 12+ Hours, Outlasting Standard Gym Bottles
18/08/2026
Dual wall vacuum insulated design is built for full gym sessions, commutes and all day use, without the drink going warm CARDIFF, United Kingdom, Aug. 18, 2026 (GLOBE NEWSWIRE) -- As gym sessions run longer through the [...]
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes
18/08/2026
Primary endpoint achieved, demonstrating a 70% economic advantage over allograft based on product cost per percent total body surface area treated (p<0.001) 96% reduction in preparation time and comparable clinical [...]
BrewDog Unwraps Its 2026 Advent Calendar
18/08/2026
New brews, bold flavours and one unmissable 24-day countdown to Christmas ELLON, United Kingdom, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Scottish craft brewer BrewDog , by Tilray Brands, Inc. , today unveiled its 2026 Advent [...]
Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond
18/08/2026
Total revenue of $46.5 million, up ~288% YoY (~3.9x); within the Company’s guidance of $46-48 million IM8 revenue of $45.0 million, up ~359% YoY (~4.6x); within the Company’s guidance of $44-46 million, marking the [...]
Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
18/08/2026
Former Intra-Cellular Therapies, Inc. (“Intra-Cellular”) executives bring complementary experience in organizational scale-up, central nervous system (“CNS”) drug development, regulatory approvals and commercialization [...]
General Oncology Nominated for the 2026 Prix Galien USA Best Startup Award
18/08/2026
Recognition follows preliminary Phase 1 results presented at ESMO Congress 2025 for GO-4 in BRCA/PALB2-mutated stage IV pancreatic ductal adenocarcinoma, where two patients remain progression-free at 48 and 23 months [...]
CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor
18/08/2026
PRESS RELEASE CHARM Therapeutics announces formation of Clinical Advisory Board to support advancement of CHM-029, its next-generation menin inhibitor LONDON – 18 August 2026 -- CHARM Therapeutics (“CHARM”, “The Company [...]
Immatics Announces Second Quarter 2026 Financial Results and Business Update
18/08/2026
Enrollment in the SUPRAME Phase 3 trial of anzu-cel (anzutresgene autoleucel, IMA203) remains on track to complete the required randomizations by year-end to support final analysis for the primary PFS endpoint; [...]
ABBYY’s New Executive Appointments Illustrate Focus on Hybrid AI to Drive Enterprise Intelligence
18/08/2026
Robert Hucik promoted to Chief Technology Officer and Joe Rayfield hired as SVP of Sales for the Americas and EMEA AUSTIN, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ABBYY today announced it promoted Robert Hucik to Chief [...]
Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development
18/08/2026
As a global medical cannabis leader, Tilray Medical supports continued policy development that strengthens physician confidence, protects patient access and provides a clear, sustainable framework for medical cannabis [...]

Pages